Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imke Masuy

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Minerva Gastroenterologica E Dietologica|December 11, 2019
Irritable bowel syndrome: diagnosis and managementImke Masuy, Jasper Pannemans, Jan Tack
Drugs|May 27, 2020
Functional Constipation: Individualising Assessment and TreatmentJasper Pannemans, Imke Masuy, Jan Tack
Alimentary Pharmacology & Therapeutics|March 30, 2019
Review article: treatment options for functional dyspepsiaImke Masuy, Lukas Van Oudenhove, Jan Tack
Neurogastroenterology and Motility|January 22, 2019
Acotiamide affects antral motility, but has no effect on fundic motility, gastric emptying or symptom perception in healthy participantsImke Masuy, Jan Tack, Kristin Verbeke, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 5, 2019
The influence of gastric motility on the intraluminal behavior of fosamprenavirMarlies Braeckmans, Joachim Brouwers, Imke Masuy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 2, 2020
Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjectsBart Hens, Imke Masuy, Eveline Deloose, et al.
Neurogastroenterology and Motility|October 15, 2019
The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia populationImke Masuy, Florencia Carbone, Lieselot Holvoet, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2019
Randomised clinical trial: the DPP-4 inhibitor, vildagliptin, inhibits gastric accommodation and increases glucagon-like peptide-1 plasma levels in healthy volunteersAlessandra Rotondo, Imke Masuy, Wout Verbeure, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2019
Editorial: effects of vildagliptin on GLP-1 levels, gastric motor functions and food intake. A authors' replyImke Masuy, Alessandra Rotondo, Wout Verbeure, et al.
The American Journal of Gastroenterology|November 19, 2019
Mechanism Underlying Symptom Benefit With Prucalopride in GastroparesisFlorencia Carbone, Karen Van den Houte, Nick Goelen, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Minerva Gastroenterologica E Dietologica|December 11, 2019
Irritable bowel syndrome: diagnosis and managementImke Masuy, Jasper Pannemans, Jan Tack
Drugs|May 27, 2020
Functional Constipation: Individualising Assessment and TreatmentJasper Pannemans, Imke Masuy, Jan Tack
Alimentary Pharmacology & Therapeutics|March 30, 2019
Review article: treatment options for functional dyspepsiaImke Masuy, Lukas Van Oudenhove, Jan Tack
Neurogastroenterology and Motility|January 22, 2019
Acotiamide affects antral motility, but has no effect on fundic motility, gastric emptying or symptom perception in healthy participantsImke Masuy, Jan Tack, Kristin Verbeke, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 5, 2019
The influence of gastric motility on the intraluminal behavior of fosamprenavirMarlies Braeckmans, Joachim Brouwers, Imke Masuy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 2, 2020
Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjectsBart Hens, Imke Masuy, Eveline Deloose, et al.
Neurogastroenterology and Motility|October 15, 2019
The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia populationImke Masuy, Florencia Carbone, Lieselot Holvoet, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2019
Randomised clinical trial: the DPP-4 inhibitor, vildagliptin, inhibits gastric accommodation and increases glucagon-like peptide-1 plasma levels in healthy volunteersAlessandra Rotondo, Imke Masuy, Wout Verbeure, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2019
Editorial: effects of vildagliptin on GLP-1 levels, gastric motor functions and food intake. A authors' replyImke Masuy, Alessandra Rotondo, Wout Verbeure, et al.
The American Journal of Gastroenterology|November 19, 2019
Mechanism Underlying Symptom Benefit With Prucalopride in GastroparesisFlorencia Carbone, Karen Van den Houte, Nick Goelen, et al.
Pageof 3